Cargando…

Drug-resistance and its impact on cutaneous tuberculosis

Drug resistance in tuberculosis is a universal health problem, with India and China having the highest number of multidrug resistant tuberculosis (MDR-TB) cases globally. As cutaneous tuberculosis (CTB) accounts for 1.5% of all extrapulmonary tuberculosis, drug resistance in CTB remains less discuss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhandari, Adhyatm, Mahajan, Rahul, Ramesh, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595148/ https://www.ncbi.nlm.nih.gov/pubmed/36304661 http://dx.doi.org/10.4103/idoj.idoj_27_22

Ejemplares similares

Unilateral Heliotrope Rash, Inverse Gottron's Papules and Anti-MDA5 Antibody Positivity: A Triad Suggesting Lung Involvement
por: Bhandari, Adhyatm, et al.
Publicado: (2022)

Strawberry Gingivitis - A Diagnostic Clue in a Male With Epistaxis and Hemoptysis
por: Bhandari, Adhyatm, et al.
Publicado: (2023)

Necrotic Cutaneous Ulceration as a Presenting Feature of Disseminated Tuberculosis in an Immunocompetent Young Adult
por: Hanumanthu, Vinod, et al.
Publicado: (2023)

Update on cutaneous tuberculosis
por: Dias, Maria Fernanda Reis Gavazzoni, et al.
Publicado: (2014)

Effect of Lockdown Due to COVID-19 on Health and Lifestyle of Psoriasis Patients: A Web-Based Survey
por: Narang, Tarun, et al.
Publicado: (2022)

Cutaneous lymphangiectasia of the vulva secondary to tuberculosis
por: Bhat, Ramesh M., et al.
Publicado: (2012)

Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
por: Agnarson, Abela Mpobela, et al.
Publicado: (2020)

Drug-resistant Spinal Tuberculosis
por: Jain, Anil K, et al.
Publicado: (2018)

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis
por: Seddon, James A., et al.
Publicado: (2016)

Cutaneous Squamous Cell Carcinoma in Lupus Vulgaris Caused by Drug Resistant Mycobacterium Tuberculosis
por: Kumaran, Muthu S., et al.
Publicado: (2017)

Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics
por: Xu, Biao, et al.
Publicado: (2014)

Drug Resistant Tuberculosis in Adults and Its Treatment
por: Drobniewski, Francis
Publicado: (1998)

Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
por: Beites, Tiago, et al.
Publicado: (2019)

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems
por: van Staden, Daniélle, et al.
Publicado: (2022)

The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Cutaneous tuberculosis
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Preventive Therapy for Contacts of Drug-Resistant Tuberculosis
por: Kherabi, Yousra, et al.
Publicado: (2022)

Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis
por: Rabaan, Ali A., et al.
Publicado: (2022)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu, Meghna, et al.
Publicado: (2011)

Extensively drug-resistant tuberculosis: epidemiology and management
por: Matteelli, Alberto, et al.
Publicado: (2014)

The role of delamanid in the treatment of drug-resistant tuberculosis
por: Lewis, Joseph M, et al.
Publicado: (2015)

Cutaneous Tuberculosis: Clinicopathologic Arrays and Diagnostic Challenges
por: Khadka, Priyatam, et al.
Publicado: (2018)

The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
por: Koch, Anastasia, et al.
Publicado: (2014)

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities
por: Ismail, Nazir, et al.
Publicado: (2018)

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control
por: Verma, Ajoy Kumar, et al.
Publicado: (2022)

Cutaneous Manifestations of Mycobacterium tuberculosis: A Literature Review
por: Nguyen, Kevin H., et al.
Publicado: (2023)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Mild cutaneous reactions to drugs
por: Giuseppe, Crisafulli, et al.
Publicado: (2019)

Living and dying with drug resistant tuberculosis - Are we doing enough?
por: Mehta, Vibha, et al.
Publicado: (2020)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis
por: Nandlal, Louansha, et al.
Publicado: (2022)

Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
por: Al-Saeedi, Mashael, et al.
Publicado: (2017)

Association between tobacco smoking and drug-resistant tuberculosis
por: Wang, Ming-Gui, et al.
Publicado: (2018)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
por: Singh, Abhijeet, et al.
Publicado: (2020)

Marine Natural Products and Drug Resistance in Latent Tuberculosis
por: Khan, Muhammad Tahir, et al.
Publicado: (2019)

The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem
por: Rocha, Deisy M. G. C., et al.
Publicado: (2021)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
por: Stephanie, Filia, et al.
Publicado: (2021)

Lupus and Cutaneous Tuberculosis
Publicado: (1888)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oapdf17lh1rrvd17kkeb68p3f7